Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.16
+0.49001.24%
Volume:64.95K
Turnover:2.63M
Market Cap:263.05M
PE:- -
High:40.62
Open:39.88
Low:39.88
Close:39.67
52wk High:41.49
52wk Low:22.18
Shares:6.55M
Float Shares:6.55M
Volume Ratio:5.70
T/O Rate:0.99%
Dividend:0.28
Dividend Rate:0.70%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports

MT Newswires Live
·
Aug 27

Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call

THOMSON REUTERS
·
Aug 27

Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval

Reuters
·
Aug 27

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

TIPRANKS
·
Aug 27

Revolution Medicines announces FDA approval of Rasonque in adults

TIPRANKS
·
Aug 27

Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.

THOMSON REUTERS
·
Aug 27

U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Aug 27

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire
·
Aug 27

US Stocks-Wall St Awaits Nvidia's AI Verdict After Hot Inflation Data

Reuters
·
Aug 27

FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease

Dow Jones
·
Aug 26

US FDA Approves Revolution Medicines' Pancreatic Cancer Drug

Reuters
·
Aug 26

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Aug 26

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

GlobeNewswire
·
Aug 26

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Aug 26

Moderna : Deutsche Bank Raises Target Price to $125 from $45

THOMSON REUTERS
·
Aug 26

Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million

Reuters
·
Aug 26

Social Buzz: Wallstreetbets Stocks Mostly Declining Pre-Bell Wednesday; Intuit, Strategy to Open Lower

MT Newswires Live
·
Aug 26

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Stock News
·
Aug 26

24H | Semtech Jumps 4%; Zoom Falls 4%; Intuit Tumbles 10% After Earnings Results

US Overnight
·
Aug 26

Review & Preview: Risky Business

Dow Jones
·
Aug 26